Strikingly, there are 35 genes regulated by SRF or IGF2BP1 in total, which in combination construct an oncogenic cellular network in HCC, making themselves valuable therapeutic targets. The gene discussed is IGF2BP1; the disease is hepatocellular carcinoma.